Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 9, Issue 2, 2010, Pages 110-116

  Sudfeld, Christopher R ^a   Dasenbrook, Elliott C ^b   Merz, William G ^a,c   Carroll, Karen C ^c   Boyle, Michael P ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Corticosteroids; Cystic fibrosis; Filamentous fungi; Prevalence

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; COLISTIN; CORTICOSTEROID; TOBRAMYCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALTERNARIA; ARTICLE; ASPERGILLOMA; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; CANDIDA ALBICANS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CURVULARIA; CYSTIC FIBROSIS; EXOPHIALA; FILAMENTOUS FUNGUS; FORCED EXPIRATORY VOLUME; FUNGAL COLONIZATION; FUNGI BY OUTER APPEARANCE; FUNGUS ISOLATION; FUSARIUM; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; NONHUMAN; PAECILOMYCES; PENICILLIUM; RISK FACTOR; SCEDOSPORIUM; SPECIES DIFFERENTIATION; TRICHOSPORON; YEAST;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; ANTI-BACTERIAL AGENTS; CHILD; COHORT STUDIES; CYSTIC FIBROSIS; DATABASES, FACTUAL; DRUG ADMINISTRATION SCHEDULE; FORCED EXPIRATORY VOLUME; FUNGI; HUMANS; MYCOSES; PREVALENCE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 76749114323     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2009.11.010     Document Type: Article

References (27)

1. Fries M.H., Bashford M., and Nunes M. Implementing prenatal screening for cystic fibrosis in routine obstetric practice. Am J Obstet Gynecol 192 (2005) 527-534
2. Brennan A.L., and Geddes D.M. Cystic fibrosis. Curr Opin Infect Dis 15 2 (2002) 175-182
3. Gibson R.L., Burns J.L., and Ramsey B.W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168 8 (2003) 918-951
4. Burns J.L., Gibson R.L., McNamara S., et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 183 3 (2001) 444-452
5. Cystic Fibrosis Foundation Patient Registry. 2001 Annual Data Report to the Center Directors (2002), Cystic Fibrosis Foundation, Bethesda, MD
6. Bakare N., Rickerts V., Bargon J., et al. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 46 1-2 (2003) 19-23
7. Amin R., Dupuis A., Aaron S.D., and Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in cystic fibrosis patients. Chest (Jun 30 2009) Epub ahead of print
8. Hankinson J.L., Odencrantz J.R., and Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159 1 (1999) 179-187
9. Wang X., Dockery D.W., Wypij D., et al. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 15 2 (1993) 75-88
10. Vittinghoff E., Shiboski S.C., Glidden D.V., et al. Regression methods in biostatistics: linear, logistic, survival, and repeated measures models (2005), Springer, New York
11. Elborn J.S. Identification and management of unusual pathogens in cystic fibrosis. J R Soc Med 101 (2008) 2-5
12. Nagano Y., Millar B.C., Johnson E., Goldsmith C.E., Elborn J.S., Rendall J., et al. Fungal infections in patients with cystic fibrosis. Rev Med Micro 18 1 (2007) 11-16
13. Shoseyov D., Brownlee K.G., Conway S.P., et al. Aspergillus bronchitis in cystic fibrosis. Chest 130 1 (2006) 222-226
14. Hutcheson P.S., Knutsen A.P., Rejent A.J., et al. A 12-year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis. Chest 110 2 (1996) 363-366
15. Lambiase A., Raia V., Del Pezzo M., et al. Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis 6 (2006) 4
16. Pihet M., Carrere J., Cimon B., et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis - a review. Med Mycol 23 (2008) 1-11
17. Burns J.L., Emerson J., Stapp J.R., et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 27 1 (1998) 158-163
18. Samarakoon P. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis 5 1 (2008) 19-27
19. Segal B.H., and Walsh T.J. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 173 7 (2006) 707-717
20. Palmer L.B., Greenberg H.E., and Schiff M.J. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 6 1 (1991) 15-20
21. Ritz N., Ammann R.A., Casaulta Aebischer C., et al. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis. Eur J Pediatr 164 9 (2005) 577-582
22. Ren C.L., Pasta D.J., Rasouliyan L., et al. Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis. J Pediatr 153 6 (2008) 746-751
23. Schmidt J., Davidson A.G.F., Seear M., et al. Is the acquisition of Pseudomonads in cystic fibrosis patients increased by use of inhaled corticosteroids? Unexpected results from a double blind placebo controlled study. Pediatr Pulmonol Suppl 14 (1997) 293-294
24. Minicucci L., Severi G., Cresta L., et al. Impact of inhaled corticosteroids on the risk of early Pseudomonas aeruginosa acquisition in cystic fibrosis. Acta Paediatr 92 (2003) 684-687
25. Stevens D.A., Moss R.B., Kurup V.P., et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 37 Suppl 3 (2003 Oct 1) S225-S264
26. Gondor M., Michaels M.G., and Finder J.D. Non-aspergillus allergic bronchopulmonary mycosis in a pediatric patient with cystic fibrosis. Pediatrics 102 6 (1998) 1480-1482
27. Nagano Y., Millar B.C., Goldsmith C.E., et al. Emergence of Scedosporium apiospermum in patients with cystic fibrosis. Arch Dis Child 92 7 (2007) 607